| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Luke J Alderwick | Q56872527 |
| P2093 | author name string | James Harrison | |
| Helen L Birch | |||
| Georgina S Lloyd | |||
| P2860 | cites work | New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis | Q21091034 |
| Identification of M. tuberculosis Rv3441c and M. smegmatis MSMEG_1556 and essentiality of M. smegmatis MSMEG_1556 | Q21134089 | ||
| The Envelope of Mycobacteria | Q22241995 | ||
| Formation of dTDP-rhamnose is essential for growth of mycobacteria | Q24539087 | ||
| Peptidoglycan types of bacterial cell walls and their taxonomic implications | Q24563299 | ||
| The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol | Q24603359 | ||
| Tetrameric structure of the GlfT2 galactofuranosyltransferase reveals a scaffold for the assembly of mycobacterial Arabinogalactan | Q24608295 | ||
| A tethering mechanism for length control in a processive carbohydrate polymerization | Q24644915 | ||
| Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-->3) arabinofuranosyltransferase | Q24656511 | ||
| Identification of a novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall | Q24678269 | ||
| Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis | Q27641941 | ||
| PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity | Q27653322 | ||
| ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation | Q27658363 | ||
| Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis | Q27666292 | ||
| Structural basis for the inhibition ofMycobacterium tuberculosisL,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains | Q27676935 | ||
| Crystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosis | Q27677374 | ||
| Identification of a small molecule with activity against drug-resistant and persistent tuberculosis | Q27678663 | ||
| Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors | Q27681391 | ||
| Crystal structures identify an atypical two-metal-ion mechanism for uridyltransfer in GlmU: its significance to sugar nucleotidyl transferases | Q27684167 | ||
| Structures of free and inhibited forms of the L,D-transpeptidase LdtMt1 from Mycobacterium tuberculosis | Q27685445 | ||
| Structural and binding properties of the PASTA domain of PonA2, a key penicillin binding protein from Mycobacterium tuberculosis | Q27687706 | ||
| Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo. | Q42708475 | ||
| Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU. | Q42731628 | ||
| Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis | Q42912341 | ||
| Conserved aspartic acids are essential for the enzymic activity of the WecA protein initiating the biosynthesis of O-specific lipopolysaccharide and enterobacterial common antigen in Escherichia coli | Q43879402 | ||
| Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques | Q44324006 | ||
| Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan | Q45136861 | ||
| Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan | Q45152585 | ||
| Rapid preparation of mycobacterium N-glycolyl Lipid I and Lipid II derivatives: a biocatalytic approach. | Q45340503 | ||
| STD-NMR studies suggest that two acceptor substrates for GlfT2, a bifunctional galactofuranosyltransferase required for the biosynthesis of Mycobacterium tuberculosis arabinogalactan, compete for the same binding site. | Q45941227 | ||
| Identification of amino acids and domains required for catalytic activity of DPPR synthase, a cell wall biosynthetic enzyme of Mycobacterium tuberculosis | Q46726125 | ||
| The lipid II flippase RodA determines morphology and growth in Corynebacterium glutamicum | Q46844312 | ||
| On the linkage between mycolic acid and arabinogalactan in phenol-treated myobacterial cell walls | Q47688428 | ||
| Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis | Q47904411 | ||
| The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. | Q48050603 | ||
| The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacterium smegmatis. | Q52611102 | ||
| Studies on cell walls of Mycobacteria. II. Constitution of polysaccharides from BCG cell walls. | Q53679858 | ||
| Enzymatic evidence for the presence of a critical terminal hexa-arabinoside in the cell walls of Mycobacterium tuberculosis. | Q54210225 | ||
| An assay for exogenous sources of purified MurG, enabled by the complementation of Escherichia coli murG(Ts) by the Mycobacterium tuberculosis homologue. | Q54348721 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| Biochemical evidence for the formation of a covalent acyl-phosphate linkage between UDP-N-acetylmuramate and ATP in the Escherichia coli UDP-N-acetylmuramate:L-alanine ligase-catalyzed reaction. | Q54593810 | ||
| Identification of a Novel Arabinofuranosyltransferase AftB Involved in a Terminal Step of Cell Wall Arabinan Biosynthesis in Corynebacterianeae, such asCorynebacterium glutamicumandMycobacterium tuberculosis | Q58040456 | ||
| Arabinan-deficient mutants of Corynebacterium glutamicum and the consequent flux in decaprenylmonophosphoryl-d-arabinose metabolism | Q58040518 | ||
| Characterization of the in vitro synthesized arabinan of mycobacterial cell walls | Q58040729 | ||
| Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay | Q58040733 | ||
| Biosynthesis of the Linkage Region of the Mycobacterial Cell Wall | Q58040740 | ||
| The Galactosamine Residue in Mycobacterial Arabinogalactan Is α-Linked | Q63360963 | ||
| Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses | Q67283043 | ||
| [Isolation of arabinose phosphate from the walls of Mycobacterium tuberculosis H 37 Ra] | Q67299016 | ||
| Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis | Q67988421 | ||
| Location of the mycolyl ester substituents in the cell walls of mycobacteria | Q67992902 | ||
| Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls | Q68556386 | ||
| Muramic acid phosphate as a component of the mucopeptide of Gram-positive bacteria | Q68565247 | ||
| Demonstration that the galactosyl and arabinosyl residues in the cell-wall arabinogalactan of Mycobacterium leprae and Mycobacterium tuberculosis are furanoid | Q70366212 | ||
| Biosynthesis in the bacterial cell wall | Q71213717 | ||
| Isolation and mass spectrometric identification of the peptide subunits of mycobacterial cell walls | Q71537005 | ||
| A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic reso | Q72125562 | ||
| Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria | Q72181562 | ||
| Chemical structure of the cell wall of Mycobacterium smegmatis. I — Isolation and partial characterization of the peptidoglycan | Q72396813 | ||
| L'acide N-glycolyl-muramique, constituant des parois de Mycobacterium smegmatis: Identification par spectrometrie de masse | Q77921782 | ||
| Formation of adenosine 5'-tetraphosphate from the acyl phosphate intermediate: a difference between the MurC and MurD synthetases of Escherichia coli | Q77993628 | ||
| A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol) | Q79081359 | ||
| Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity | Q87855071 | ||
| Chemical analyses of mycobacterial cell walls | Q93767241 | ||
| Use of bacteriolytic enzymes in determination of wall structure and their role in cell metabolism | Q40871593 | ||
| Evidence for the incorporation of molecular oxygen, a pathway in biosynthesis of N-glycolylmuramic acid in Mycobacterium phlei | Q41043993 | ||
| A role for the class A penicillin-binding protein PonA2 in the survival of Mycobacterium smegmatis under conditions of nonreplication | Q41787109 | ||
| Galactosamine in walls of slow-growing mycobacteria | Q41836041 | ||
| Benzothiazinones mediate killing of Corynebacterineae by blocking decaprenyl phosphate recycling involved in cell wall biosynthesis | Q41984312 | ||
| Formation of the glycan chains in the synthesis of bacterial peptidoglycan | Q28185380 | ||
| Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine | Q28282522 | ||
| Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis | Q28327991 | ||
| Study of the formation of N-glycolylmuramic acid from Nocardia asteroides (author's transl) | Q28341963 | ||
| Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis | Q28359728 | ||
| High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors | Q28471626 | ||
| Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis | Q28486345 | ||
| Expression, purification and characterisation of soluble GlfT and the identification of a novel galactofuranosyltransferase Rv3782 involved in priming GlfT-mediated galactan polymerisation in Mycobacterium tuberculosis | Q28486429 | ||
| Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis | Q28486563 | ||
| rmlB and rmlC genes are essential for growth of mycobacteria | Q28486579 | ||
| Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase | Q28486586 | ||
| The serine/threonine kinase PknB of Mycobacterium tuberculosis phosphorylates PBPA, a penicillin-binding protein required for cell division | Q28486785 | ||
| Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose | Q28486790 | ||
| Mycobacterium tuberculosis Rv1302 and Mycobacterium smegmatis MSMEG_4947 have WecA function and MSMEG_4947 is required for the growth of M. smegmatis | Q28486792 | ||
| Construction and use of low-copy number T7 expression vectors for purification of problem proteins: purification of mycobacterium tuberculosis RmlD and pseudomonas aeruginosa LasI and RhlI proteins, and functional analysis of purified RhlI | Q28486796 | ||
| Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis | Q28486804 | ||
| Determination of the pathway for rhamnose biosynthesis in mycobacteria: cloning, sequencing and expression of the Mycobacterium tuberculosis gene encoding alpha-D-glucose-1-phosphate thymidylyltransferase | Q28486841 | ||
| Mycobacterium tuberculosis RmlC epimerase (Rv3465): a promising drug-target structure in the rhamnose pathway | Q28486876 | ||
| Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues | Q28486923 | ||
| Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose | Q28486980 | ||
| Biochemical characterization of the Mycobacterium tuberculosis phosphoribosyl-1-pyrophosphate synthetase | Q28487197 | ||
| Comparison of the UDP-N-acetylmuramate:L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae | Q28487429 | ||
| Characterization of CrgA, a new partner of the Mycobacterium tuberculosis peptidoglycan polymerization complexes | Q28487435 | ||
| Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase | Q28487466 | ||
| Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability | Q28487566 | ||
| Conversion of dTDP-4-keto-6-deoxyglucose to free dTDP-4-keto-rhamnose by the rmIC gene products of Escherichia coli and Mycobacterium tuberculosis | Q28487619 | ||
| Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability | Q28501832 | ||
| Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core | Q33220238 | ||
| Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifs | Q33266918 | ||
| The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan | Q33321365 | ||
| Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics | Q33540441 | ||
| Interaction and modulation of two antagonistic cell wall enzymes of mycobacteria. | Q33649862 | ||
| A truncated lipoglycan from mycobacteria with altered immunological properties | Q33664341 | ||
| N Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment | Q33716658 | ||
| The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. | Q33778121 | ||
| Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant properties | Q34013861 | ||
| Molecular mechanics of the mycobacterial cell wall: from horizontal layers to vertical scaffolds | Q34014265 | ||
| Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane | Q34169371 | ||
| Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1. | Q34242071 | ||
| Structure-function analysis of MurJ reveals a solvent-exposed cavity containing residues essential for peptidoglycan biogenesis in Escherichia coli | Q34363302 | ||
| Three-dimensional structure of the bacterial cell wall peptidoglycan | Q34574689 | ||
| Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis | Q34579687 | ||
| Functional characterization and membrane topology of Escherichia coli WecA, a sugar-phosphate transferase initiating the biosynthesis of enterobacterial common antigen and O-antigen lipopolysaccharide | Q34604149 | ||
| Three monophyletic superfamilies account for the majority of the known glycosyltransferases | Q34648585 | ||
| The methyl-branched fortifications of Mycobacterium tuberculosis | Q34657803 | ||
| Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones | Q34726267 | ||
| Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli | Q34843809 | ||
| The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)? | Q35876950 | ||
| A small multidrug resistance-like transporter involved in the arabinosylation of arabinogalactan and lipoarabinomannan in mycobacteria | Q36407935 | ||
| Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer | Q36407940 | ||
| Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. | Q36575914 | ||
| The glycosyltransferases of Mycobacterium tuberculosis - roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates | Q36721545 | ||
| Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli | Q36846963 | ||
| Cytoplasmic steps of peptidoglycan biosynthesis | Q37081699 | ||
| Highlights of glucosamine-6P synthase catalysis | Q37086239 | ||
| Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45 | Q37234023 | ||
| AftD, a novel essential arabinofuranosyltransferase from mycobacteria | Q37376674 | ||
| Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis | Q37519148 | ||
| Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams | Q37713160 | ||
| A Burkholderia cenocepacia MurJ (MviN) homolog is essential for cell wall peptidoglycan synthesis and bacterial viability | Q39000262 | ||
| Cell wall core galactofuran synthesis is essential for growth of mycobacteria | Q39503992 | ||
| Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine | Q39730806 | ||
| Tertiary Structure of Bacterial Murein: the Scaffold Model | Q39753941 | ||
| Biogenesis of the mycobacterial cell wall and the site of action of ethambutol | Q39780773 | ||
| A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis | Q39785399 | ||
| Biosynthetic origin of mycobacterial cell wall arabinosyl residues | Q39839519 | ||
| Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase | Q39840295 | ||
| Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis | Q39855786 | ||
| Nucleotide sequences of the gal E gene and the gal T gene of E. coli | Q40418917 | ||
| The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. | Q40679743 | ||
| P433 | issue | 8 | |
| P921 | main subject | cell wall | Q128700 |
| P304 | page(s) | a021113 | |
| P577 | publication date | 2015-03-27 | |
| P1433 | published in | Cold Spring Harbor Perspectives in Medicine | Q21042440 |
| P1476 | title | The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan | |
| P478 | volume | 5 |
| Q37098870 | A cytoplasmic peptidoglycan amidase homologue controls mycobacterial cell wall synthesis |
| Q92857509 | A paucity of knowledge regarding nontuberculous mycobacterial lipids compared to the tubercle bacillus |
| Q64097921 | Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex |
| Q47396139 | Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of Mycob |
| Q57791109 | Breaking down walls |
| Q64087615 | Cell Wall Hydrolases in Bacteria: Insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan |
| Q64121414 | Characterization of putative DD-carboxypeptidase-encoding genes in Mycobacterium smegmatis |
| Q129066712 | Chemical Synthesis of Cell Wall Constituents of Mycobacterium tuberculosis |
| Q90172881 | Designing, synthesis and characterization of 2-aminothiazole-4-carboxylate Schiff bases; antimicrobial evaluation against multidrug resistant strains and molecular docking |
| Q43378629 | Deviant Behavior: Tick-Borne Pathogens and Inflammasome Signaling. |
| Q53065866 | Down-regulation of N-acetylglucosamine-1-phosphate transferase (WecA) enhanced the sensitivity of Mycobacterium smegmatis against rifampin. |
| Q39276458 | Esx Systems and the Mycobacterial Cell Envelope: What's the Connection? |
| Q92715362 | Genome-wide SNP and InDel mutations in Mycobacterium tuberculosis associated with rifampicin and isoniazid resistance |
| Q90296276 | Global phenotypic profiling identifies a conserved actinobacterial cofactor for a bifunctional PBP-type cell wall synthase |
| Q92772472 | Identification of new components of the RipC-FtsEX cell separation pathway of Corynebacterineae |
| Q48125360 | Impact of mycolic acid deficiency on cells of Corynebacterium glutamicum ATCC13869. |
| Q91877791 | Intracellular Mycobacterium tuberculosis Exploits Multiple Host Nitrogen Sources during Growth in Human Macrophages |
| Q90468101 | Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics |
| Q90206059 | Mycobacterial Membrane Domain, or a Primordial Organelle? |
| Q35245286 | Mycobacterium tuberculosis metabolism |
| Q33600161 | New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria |
| Q91807571 | New tuberculosis drug targets, their inhibitors, and potential therapeutic impact |
| Q60046884 | Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption |
| Q91344605 | Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies |
| Q57319273 | Prediction of Antitubercular Peptides From Sequence Information Using Ensemble Classifier and Hybrid Features |
| Q38989303 | Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis |
| Q64249427 | Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis |
| Q92442268 | Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies |
| Q46537326 | Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure |
| Q38973367 | The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
| Q92879488 | The Cell Wall Hydrolytic NlpC/P60 Endopeptidases in Mycobacterial Cytokinesis: A Structural Perspective |
| Q92526693 | The MarR-Type Regulator MalR Is Involved in Stress-Responsive Cell Envelope Remodeling in Corynebacterium glutamicum |
| Q89926088 | The endogenous galactofuranosidase GlfH1 hydrolyzes mycobacterial arabinogalactan |
| Q91287193 | The mycobacterial cell envelope - a moving target |
| Q92857461 | Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
| Q38811605 | β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis |
Search more.